People: Impax Laboratories Inc (IPXL.OQ)
23 May 2017
Mr. Mark A. Schlossberg Esq is Senior Vice President, General Counsel, Corporate Secretary of Impax Laboratories Inc. He has served as our Senior Vice President, General Counsel and Corporate Secretary since May 2011. Since September 2015, he has served on the board of directors of Immunocelluar Therapeutics Ltd (NYSE: IMUC), a clinical-stage company focused on the development of immune-based therapies for the treatment of brain and other cancers based in Los Angeles, California. Prior to joining us, he served as Vice President, Associate General Counsel of Amgen Inc. human therapeutics biotechnology company, from September 2004 to May 2011. Prior to joining Amgen, he held legal and business positions at Medtronic, Inc. a medical technology company and legal positions at Diageo plc, RJR Nabisco, Inc. and Mudge Rose Guthrie Alexander & Ferdon. He earned a Bachelor of Sciences in business administration, finance from the University of Southern California and a Juris Doctor degree from Emory University.
|Total Annual Compensation, USD||515,045|
|Restricted Stock Awards, USD||727,016|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||749,419|
|Fiscal Year Total, USD||1,991,480|